{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:48:31Z","timestamp":1759837711962},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.amjcard.2013.12.044","type":"journal-article","created":{"date-parts":[[2014,2,2]],"date-time":"2014-02-02T06:22:02Z","timestamp":1391322122000},"page":"1362-1363","source":"Crossref","is-referenced-by-count":35,"title":["Safety of Short-Term Use of Dabigatran or Rivaroxaban for Direct-Current Cardioversion in Patients With Atrial Fibrillation and Atrial Flutter"],"prefix":"10.1016","volume":"113","author":[{"given":"Ajay","family":"Yadlapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Groh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod","family":"Passman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2013.12.044_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/01.CIR.14.5.745","article-title":"The effect of external electric currents on the heart; control of cardiac rhythm and induction and termination of cardiac arrhythmias","volume":"14","author":"Gibson","year":"1956","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.12.044_bib2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archinte.1995.00430130019003","article-title":"Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies","volume":"155","author":"Kinch","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2013.12.044_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0735-1097(92)90530-Z","article-title":"Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter","volume":"19","author":"Arnold","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.12.044_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0002-9149(89)90264-6","article-title":"Anticoagulation for cardioversion of atrial fibrillation","volume":"63","author":"Weinberg","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.12.044_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0002-9149(98)00007-1","article-title":"Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (The ACUTE Multicenter Study). Steering and Publications Committees of the ACUTE Study","volume":"81","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.12.044_bib6","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/jm0109513","article-title":"Structure-based design of novel potent nonpeptide thrombin inhibitors","volume":"45","author":"Hauel","year":"2002","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.amjcard.2013.12.044_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/ATVBAHA.110.202978","article-title":"Rivaroxaban: a new oral factor Xa inhibitor","volume":"30","author":"Perzborn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2013.12.044_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1472-8206.2011.00981.x","article-title":"Pharmacodynamic and pharmacokinetic basics of rivaroxaban","volume":"26","author":"Kreutz","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2013.12.044_bib9","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1161\/STROKEAHA.111.000402","article-title":"Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation","volume":"44","author":"Harrington","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2013.12.044_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-154-1-201101040-00289","article-title":"Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation","volume":"154","author":"Freeman","year":"2011","journal-title":"Ann Intern Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914914005529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914914005529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T19:51:18Z","timestamp":1538855478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914914005529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0002914914005529"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2013.12.044","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}